ACADIA Pharmaceuticals Inc (ACAD)
16.57
+0.26
(+1.59%)
USD |
NASDAQ |
Apr 26, 13:40
ACADIA Pharmaceuticals Total Liabilities (Quarterly): 317.20M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 317.20M |
| September 30, 2023 | 270.37M |
| June 30, 2023 | 246.98M |
| March 31, 2023 | 281.05M |
| December 31, 2022 | 187.40M |
| September 30, 2022 | 176.80M |
| June 30, 2022 | 177.92M |
| March 31, 2022 | 179.45M |
| December 31, 2021 | 159.23M |
| September 30, 2021 | 150.72M |
| June 30, 2021 | 159.59M |
| March 31, 2021 | 173.57M |
| December 31, 2020 | 155.61M |
| September 30, 2020 | 140.80M |
| June 30, 2020 | 96.64M |
| March 31, 2020 | 109.07M |
| December 31, 2019 | 84.05M |
| September 30, 2019 | 76.30M |
| June 30, 2019 | 71.97M |
| March 31, 2019 | 82.75M |
| December 31, 2018 | 61.12M |
| September 30, 2018 | 43.02M |
| June 30, 2018 | 50.24M |
| March 31, 2018 | 46.87M |
| December 31, 2017 | 49.22M |
| Date | Value |
|---|---|
| September 30, 2017 | 36.39M |
| June 30, 2017 | 41.18M |
| March 31, 2017 | 45.49M |
| December 31, 2016 | 42.74M |
| September 30, 2016 | 39.33M |
| June 30, 2016 | 29.22M |
| March 31, 2016 | 21.34M |
| December 31, 2015 | 22.13M |
| September 30, 2015 | 17.97M |
| June 30, 2015 | 19.72M |
| March 31, 2015 | 16.87M |
| December 31, 2014 | 15.97M |
| September 30, 2014 | 11.27M |
| June 30, 2014 | 9.357M |
| March 31, 2014 | 8.046M |
| December 31, 2013 | 6.987M |
| September 30, 2013 | 18.53M |
| June 30, 2013 | 25.43M |
| March 31, 2013 | 23.35M |
| December 31, 2012 | 23.61M |
| September 30, 2012 | 6.086M |
| June 30, 2012 | 9.166M |
| March 31, 2012 | 8.934M |
| December 31, 2011 | 8.752M |
| September 30, 2011 | 8.878M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
71.97M
Minimum
Jun 2019
317.20M
Maximum
Dec 2023
169.19M
Average
159.59M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 48.93M |
| Amylyx Pharmaceuticals Inc | 84.02M |
| Regulus Therapeutics Inc | 9.563M |
| Minerva Neurosciences Inc | 85.36M |
| Viking Therapeutics Inc | 33.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 748.96M |
| Shareholders Equity (Quarterly) | 431.76M |
| Current Ratio | 2.423 |